Investing Ideas
/
Chinese Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Chinese Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

High return on equity, past performance and sound balance sheet.

1 companies

Shandong Wit Dyne HealthLtd

Market Cap: CN¥7.6b

Engages in the pharmaceutical business in China.

000915

CN¥32.64

-1.4%

10.3%